Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 49

1.

Desmoplastic small round cell tumors: Multimodality treatment and new risk factors.

Scheer M, Vokuhl C, Blank B, Hallmen E, von Kalle T, Münter M, Wessalowski R, Hartwig M, Sparber-Sauer M, Schlegel PG, Kramm CM, Kontny U, Spriewald B, Kegel T, Bauer S, Kazanowska B, Niggli F, Ladenstein R, Ljungman G, Jahnukainen K, Fuchs J, Bielack SS, Klingebiel T, Koscielniak E; Cooperative Weichteilsarkom Studiengruppe [CWS].

Cancer Med. 2019 Feb;8(2):527-542. doi: 10.1002/cam4.1940. Epub 2019 Jan 16.

2.

Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial.

Issels RD, Lindner LH, Verweij J, Wessalowski R, Reichardt P, Wust P, Ghadjar P, Hohenberger P, Angele M, Salat C, Vujaskovic Z, Daugaard S, Mella O, Mansmann U, Dürr HR, Knösel T, Abdel-Rahman S, Schmidt M, Hiddemann W, Jauch KW, Belka C, Gronchi A; European Organization for the Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group and the European Society for Hyperthermic Oncology.

JAMA Oncol. 2018 Apr 1;4(4):483-492. doi: 10.1001/jamaoncol.2017.4996. Erratum in: JAMA Oncol. 2018 Apr 1;4(4):590.

3.

Neo-adjuvant chemotherapy alone or with regional hyperthermia for soft-tissue sarcoma - Authors' reply.

Issels RD, Lindner LH, Wessalowski R, Mansmann U.

Lancet Oncol. 2017 Nov;18(11):e630. doi: 10.1016/S1470-2045(17)30809-4. Epub 2017 Oct 31. No abstract available.

PMID:
29208384
4.

Challenges in the local treatment of large abdominal embryonal rhabdomyosarcoma.

Dantonello TM, Lochbühler H, Schuck A, Kube S, Godzinski J, Sköldenberg E, Ljungman G, Kosztyla D, Veit-Friedrich I, Hallmen E, Feuchtgruber S, Wessalowski R, Franke M, Bielack SS, Klingebiel T, Koscielniak E.

Ann Surg Oncol. 2014 Oct;21(11):3579-86. doi: 10.1245/s10434-014-3551-7. Epub 2014 Jul 22.

PMID:
25047462
5.

Salvage treatment of relapsed or refractory germ-cell tumours - authors' reply.

Wessalowski R, Schneider DT, Göbel U, Calaminus G; MAKEI study group.

Lancet Oncol. 2013 Nov;14(12):e486-7. doi: 10.1016/S1470-2045(13)70474-1. No abstract available.

PMID:
24176561
6.

Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study.

Wessalowski R, Schneider DT, Mils O, Friemann V, Kyrillopoulou O, Schaper J, Matuschek C, Rothe K, Leuschner I, Willers R, Schönberger S, Göbel U, Calaminus G; MAKEI study group.

Lancet Oncol. 2013 Aug;14(9):843-52. doi: 10.1016/S1470-2045(13)70271-7. Epub 2013 Jul 1.

PMID:
23823158
7.

Epidemiology and clinical characteristics of pandemic (H1N1) 2009 influenza infection in pediatric hemato-oncology and hematopoietic stem cell transplantation patients.

Babor F, Grund S, Siepermann M, Oommen PT, Kuhlen M, Schuster FR, Laws HJ, Wessalowski R, Bienemann K, Janßen G, Adams O, Borkhardt A, Meisel R.

Transpl Infect Dis. 2012 Dec;14(6):589-94. doi: 10.1111/tid.12013. Epub 2012 Sep 26.

PMID:
23013490
8.

Contribution of novel ATGL missense mutations to the clinical phenotype of NLSD-M: a strikingly low amount of lipase activity may preserve cardiac function.

Tavian D, Missaglia S, Redaelli C, Pennisi EM, Invernici G, Wessalowski R, Maiwald R, Arca M, Coleman RA.

Hum Mol Genet. 2012 Dec 15;21(24):5318-28. doi: 10.1093/hmg/dds388. Epub 2012 Sep 17.

9.

Guideline for the clinical application, documentation and analysis of clinical studies for regional deep hyperthermia: quality management in regional deep hyperthermia.

Bruggmoser G, Bauchowitz S, Canters R, Crezee H, Ehmann M, Gellermann J, Lamprecht U, Lomax N, Messmer MB, Ott O, Abdel-Rahman S, Schmidt M, Sauer R, Thomsen A, Wessalowski R, van Rhoon G; Atzelsberg Research Group; European Society for Hyperthermic Oncology.

Strahlenther Onkol. 2012 Sep;188 Suppl 2:198-211. doi: 10.1007/s00066-012-0176-2. No abstract available.

PMID:
22926657
10.

Invasive aspergillosis in pediatric oncology patients: a rare event with poor prognosis--case analysis to plan better targeted prophylactic or therapeutic measurement.

Babor F, Schuster F, Mackenzie C, Meisel R, Schaper J, Sabir H, Siepermann M, Wessalowski R, Janßen G, Borkhardt A, Laws HJ.

Klin Padiatr. 2012 Apr;224(3):160-5. doi: 10.1055/s-0032-1304625. Epub 2012 Apr 13.

PMID:
22504775
11.

Oral low-dose chemotherapy: successful treatment of an alveolar rhabdomyosarcoma during pregnancy.

Siepermann M, Koscielniak E, Dantonello T, Klee D, Boos J, Krefeld B, Borkhardt A, Hoehn T, Asea A, Wessalowski R.

Pediatr Blood Cancer. 2012 Jan;58(1):104-6. doi: 10.1002/pbc.22934. Epub 2011 Jan 16.

12.

Quality assurance for clinical studies in regional deep hyperthermia.

Bruggmoser G, Bauchowitz S, Canters R, Crezee H, Ehmann M, Gellermann J, Lamprecht U, Lomax N, Messmer MB, Ott O, Abdel-Rahman S, Sauer R, Schmidt M, Thomsen A, Wessalowski R, van Rhoon G; ESHO Technical Committee in the Interdisciplinary Working Group Hyperthermia (IAH) in the German Cancer Society.

Strahlenther Onkol. 2011 Oct;187(10):605-10. doi: 10.1007/s00066-011-1145-x. Epub 2011 Sep 19.

PMID:
21932026
13.

Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study.

Issels RD, Lindner LH, Verweij J, Wust P, Reichardt P, Schem BC, Abdel-Rahman S, Daugaard S, Salat C, Wendtner CM, Vujaskovic Z, Wessalowski R, Jauch KW, Dürr HR, Ploner F, Baur-Melnyk A, Mansmann U, Hiddemann W, Blay JY, Hohenberger P; European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group (EORTC-STBSG); European Society for Hyperthermic Oncology (ESHO).

Lancet Oncol. 2010 Jun;11(6):561-70. doi: 10.1016/S1470-2045(10)70071-1. Epub 2010 Apr 29.

14.

Solitary spinal epidural cavernous angiomas in children presenting with acute neurological symptoms caused by hemorrhage.

Sarikaya-Seiwert S, Gierga K, Wessalowski R, Steiger HJ, Hänggi D.

J Neurosurg Pediatr. 2010 Jan;5(1):89-93. doi: 10.3171/2009.7.PEDS09203.

PMID:
20043742
15.

Long time survival after reduced chemotherapy ina 15-year-old patient with AML and Candida krusei sepsis and eye involvement.

Bernbeck B, Janssen G, Winterhalter S, Schneider DT, Wessalowski R.

Klin Padiatr. 2009 Nov-Dec;221(6):384-5. doi: 10.1055/s-0029-1239536. Epub 2009 Nov 4.

PMID:
19890793
16.

Symptoms of childhood acute lymphoblastic leukemia: red flags to recognize leukemia in daily practice.

Bernbeck B, Wüller D, Janssen G, Wessalowski R, Göbel U, Schneider DT.

Klin Padiatr. 2009 Nov-Dec;221(6):369-73. doi: 10.1055/s-0029-1239538. Epub 2009 Nov 4.

PMID:
19890789
17.

Hyperthermia associated osteonecrosis in young patients with pelvic malignancies.

Jäger M, Balzer S, Wessalowski R, Schaper J, Göbel U, Li X, Krauspe R.

Anticancer Agents Med Chem. 2008 Jun;8(5):571-5.

PMID:
18537538
18.

Serial intense chemotherapy combining topotecan, etoposide, carboplatin and cyclophosphamide (TECC) followed by autologous hematopoietic stem cell support in patients with high risk soft tissue sarcoma (STS).

Bernbeck B, Bahci S, Meisel R, Troeger A, Schönberger S, Laws HJ, Kramm C, Wessalowski R, Koscielniak E, Dilloo D, Göbel U.

Klin Padiatr. 2007 Nov-Dec;219(6):318-22.

PMID:
18050041
19.

High nerve growth factor receptor (p75NTR) expression is a favourable prognostic factor in paediatric B cell precursor-acute lymphoblastic leukaemia.

Troeger A, Gudowius S, Escherich G, den Boer ML, Glouchkova L, Ackermann B, Meisel R, Laws HJ, Groeger M, Wessalowski R, Willers R, Harbott J, Pieters R, Goebel U, Janka-Schaub GE, Hanenberg H, Dilloo D.

Br J Haematol. 2007 Nov;139(3):450-7.

PMID:
17910636
20.

Impact of reduction of therapy on infectious complications in childhood acute lymphoblastic leukemia.

Graubner UB, Porzig S, Jorch N, Kolb R, Wessalowski R, Escherich G, Janka GE.

Pediatr Blood Cancer. 2008 Feb;50(2):259-63.

PMID:
17635005

Supplemental Content

Loading ...
Support Center